David J. Lockhart
2011
In 2011, David J. Lockhart earned a total compensation of $1.1M as Chief scientific officer at Amicus Therapeutics, a 80% increase compared to previous year.
Compensation breakdown
| Bonus | $121,197 |
|---|---|
| Option Awards | $564,344 |
| Salary | $378,741 |
| Other | $13,001 |
| Total | $1,077,283 |
Lockhart received $564.3K in option awards, accounting for 52% of the total pay in 2011.
Lockhart also received $121.2K in bonus, $378.7K in salary and $13K in other compensation.
Rankings
In 2011, David J. Lockhart's compensation ranked 5,387th out of 10,747 executives tracked by ExecPay. In other words, Lockhart earned more than 49.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,387 out of 10,747 | 50th |
Division Manufacturing | 1,954 out of 3,960 | 51st |
Major group Chemicals And Allied Products | 425 out of 1,033 | 59th |
Industry group Drugs | 266 out of 781 | 66th |
Industry Pharmaceutical Preparations | 207 out of 571 | 64th |
Source: SEC filing on April 28, 2014.
Lockhart's colleagues
We found six more compensation records of executives who worked with David J. Lockhart at Amicus Therapeutics in 2011.
2011
John Crowley
Amicus Therapeutics
Chief Executive Officer
2011
Matthew Patterson
Amicus Therapeutics
Former President
2011
Pol Boudes
Amicus Therapeutics
Chief Medical Officer
2011
Bradley Campbell
Amicus Therapeutics
Chief Operating Officer
2011
Daphne Quimi
Amicus Therapeutics
Controller and Former Principal Financial Officer
2011
Mohan Ganesan
Amicus Therapeutics